1. Performance Analysis of Algorithm (consolidated) 048410 Date
Period 3 months 100-m won
2016.12 2017.12 2018.12 Average 2018.06 2018.09 2018.12 2019.03 2019.06 2019.09
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 361 320 319 333 87 75 96 78 78 77 84
O-profit -70 15 16 -13 6 4 2 7 11 17 5
N-income -81 12 26 -14 1 7 21 6 21 71 9
O-rate -19.4 4.7 5.0 -3.2 6.9 5.3 2.1 9.0 14.1 22.2 5.8
N-rate -22.4 3.8 8.2 -3.5 1.1 9.3 21.9 7.7 26.6 91.9 10.0
ROE -44.5 3.9 6.4 -11.4 1.3 4.5 8.8 5.0 7.3 13.0 4.9
Debt-ratio 193.4 60.2 33.3 95.6 65.3 40.7 33.3 47.8 44.5 41.4 46.8
Quick-ratio 110.8 164.9 277.2 184.3 186.8 285.7 277.2 252.0 301.9 375.4 250.4
reserve-ratio 95.4 157.1 200.6 151.0 155.8 180.8 200.6 219.4 227.8 236.4 189.2
EPS -234 35 75 -41 3 20 61 17 60 205 25
BPS 525 892 1,169 862 898 1,051 1,169 1,256 1,418 1,601 1,093
Dividends 0 0 0 0
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
2019-08-16
Gap
(Indication /
stock)
Color
High price ~ -20 %
High mid ~ -31 %
Mid ~ -42 %
Low mid ~ -53 %
Low price ~ -64 %
Sell
4,384 W 4,384 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Cosmetics 81 9 3,009 1,108
8,402 W 8,402 W 7,063 W
7,063 W 7,063 W 5,723 W Evaluation
9,741 W 9,741 W~ 8,402 W
12,250 W
38.85,723 W 5,723 W 4,384 W
High price
Indication price Range Current stock price Company score
4,384원
5,723원
7,063원
8,402원
9,741원
High price 12,250원
-64%
-53%
-42%
-31%
-20%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
2,000W
4,000W
6,000W
8,000W
10,000W
12,000W
14,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
hyundai bioscience
Gap
hyundai bioscience
2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 048410 Date
Period
Gap
(Indication /
stock)
Color
low price 4,384 W 4,384 W ~ 0 W -64 % 145,355 W 33
Low mid 5,723 W 5,723 W ~ 4,384 W -53 % 120,607 W 21
Mid 7,063 W 7,063 W ~ 5,723 W -42 % 95,859 W 14
High mid 8,402 W 8,402 W ~ 7,063 W -31 % 71,111 W 8
Suggested Purchase
Amount 226,374 W
Number of stocks
purchased 18
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 9,741 W 9,741 W~ ~ 8,402 W -20 % 46,362 W 5
2019-08-16
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
12,250 W High price 51.9 Sell 1,000,000 W
42.1 32.4 44.4 37.9 44.0 30.9
2019.03.22 2019.04.19 2019.05.21 2019.06.19 2019.07.17 2019.08.14
Stock price rise
probability score
A Sector 45.2 51.6 51.7 45.1 47.5 48.0
51.9B Sector 38.9 13.1 37.1 45.1 40.4 13.8
Total average
2019.05.21 2019.06.19 2019.07.17 2019.08.14
Total of
increase rate
Total score
A Sector 12 % 0 % -15 % 5 % 1 %
-10 % 42.3B Sector -196 % 65 % 18 % -12 % -194 %
Total average -30 % 27 % -17 % 14 % -42 %
2019.04.19
45
52 52
45 48 48
39
13
37
45
40
14
42
32
44
38
44
31
0
10
20
30
40
50
60
2019.03.22 2019.04.19 2019.05.21 2019.06.19 2019.07.17 2019.08.14
Stock price rise probability score
A sector
B sector
Total average
12% 0%
-15%
5% 1%
-196%
65%
18%
-12%
-194%
-30%
27%
-17%
14%
-42%
-250%
-200%
-150%
-100%
-50%
0%
50%
100%
2019.04.19 2019.05.21 2019.06.19 2019.07.17 2019.08.14
Increase rate of stock price rise
A sector
B sector
Total average
hyundai bioscience
3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting
The Algori
accuracy o
change ove
results of
Consulting
②
informatio
investmen
up
③
do anythin
transaction
④
The Algori
informatio
⑤
analysis re